Oncternal Therapeutics Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Millions ARS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2018	2016 - 2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '18 Dec 31, 2018	2016 - 2020
Market Capitalization	284,812	385,097	-	-	-	-	Upgrade
Enterprise Value	258,773	350,249	-	-	-	-	Upgrade
PE Ratio	7.57	19.85	-	-	-	-	Upgrade
PS Ratio	0.96	1.56	-	-	-	-	Upgrade
PB Ratio	1.57	2.07	-	-	-	-	Upgrade
P/FCF Ratio	4.78	8.47	-	-	-	-	Upgrade
P/OCF Ratio	4.12	7.17	-	-	-	-	Upgrade
EV/Sales Ratio	0.87	1.42	-	-	-	-	Upgrade
EV/EBITDA Ratio	3.44	6.09	-	-	-	-	Upgrade
EV/EBIT Ratio	4.17	7.70	-	-	-	-	Upgrade
EV/FCF Ratio	4.34	7.70	-	-	-	-	Upgrade
Quick Ratio	1.00	1.35	1.15	1.17	1.11	1.22	Upgrade
Current Ratio	1.04	1.40	1.26	1.25	1.19	1.29	Upgrade
Asset Turnover	0.97	0.91	0.84	0.98	-	1.16	Upgrade
Return on Equity (ROE)	21.76%	11.00%	7.06%	-5.04%	-	30.94%	Upgrade
Return on Assets (ROA)	13.65%	10.45%	-2.54%	0.47%	-	17.00%	Upgrade
Return on Capital (ROIC)	24.40%	16.12%	-3.68%	0.70%	-	27.70%	Upgrade
Return on Capital Employed (ROCE)	26.90%	19.60%	-	0.60%	2.70%	34.90%	Upgrade
Earnings Yield	13.20%	5.04%	-	-	-	-	Upgrade
Earnings Yield	13.20%	5.04%	-	-	-	-	Upgrade
FCF Yield	20.91%	11.80%	-	-	-	-	Upgrade
Dividend Yield	14.05%	8.40%	-	-	-	-	Upgrade
Payout Ratio	-	-	333.67%	-	-	74.48%	Upgrade
Total Shareholder Return	13.82%	8.40%	-	-	-	-	Upgrade

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.